Sequential combination therapy in e-antigen positive patients with chronic hepatitis B (CHB). Interim results of an open-label controlled trial of lamivudine followed by pegylated interferon α 2b versus pegylated interferon α 2b alone

337

  • Madan, Kaushal
  • Baba, Chalamalashety Srinivas
  • Batra, Yogesh
  • Kalra, Nancy
  • Kumar, Shakti
  • Gupta, Siddarth Datta
  • Jha, Jyotish K
  • Panda, Subrat K
  • Acharya, Subrat K

  • *Departments of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India

    †Departments of Pathology, All India Institute of Medical Sciences, New Delhi, India

Journal of Gastroenterology & Hepatology 21:p A454, November 2006.
Copyright © 2006 Blackwell Publishing Ltd.
View full text|Download PDF